BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33977963)

  • 1.
    Zheng F; Wang Z; Stanton C; Ross RP; Zhao J; Zhang H; Yang B; Chen W
    Food Funct; 2021 May; 12(9):3919-3930. PubMed ID: 33977963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-obesity effect of Lactobacillus rhamnosus LS-8 and Lactobacillus crustorum MN047 on high-fat and high-fructose diet mice base on inflammatory response alleviation and gut microbiota regulation.
    Wang T; Yan H; Lu Y; Li X; Wang X; Shan Y; Yi Y; Liu B; Zhou Y; Lü X
    Eur J Nutr; 2020 Sep; 59(6):2709-2728. PubMed ID: 31659451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactobacillus reuteri improves gut barrier function and affects diurnal variation of the gut microbiota in mice fed a high-fat diet.
    Li S; Qi C; Zhu H; Yu R; Xie C; Peng Y; Yin SW; Fan J; Zhao S; Sun J
    Food Funct; 2019 Aug; 10(8):4705-4715. PubMed ID: 31304501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways.
    Wang G; Jiao T; Xu Y; Li D; Si Q; Hao J; Zhao J; Zhang H; Chen W
    Food Funct; 2020 Jul; 11(7):6115-6127. PubMed ID: 32573567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
    Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
    Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity.
    Oh JH; Schueler KL; Stapleton DS; Alexander LM; Yen CE; Keller MP; Attie AD; van Pijkeren JP
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo screening of multiple bacterial strains identifies Lactobacillus rhamnosus Lb102 and Bifidobacterium animalis ssp. lactis Bf141 as probiotics that improve metabolic disorders in a mouse model of obesity.
    Le Barz M; Daniel N; Varin TV; Naimi S; Demers-Mathieu V; Pilon G; Audy J; Laurin É; Roy D; Urdaci MC; St-Gelais D; Fliss I; Marette A
    FASEB J; 2019 Apr; 33(4):4921-4935. PubMed ID: 30596521
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wang G; Zhu G; Chen C; Zheng Y; Ma F; Zhao J; Lee YK; Zhang H; Chen W
    Benef Microbes; 2021 Jun; 12(3):267-281. PubMed ID: 34109894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR).
    Tenorio-Jiménez C; Martínez-Ramírez MJ; Tercero-Lozano M; Arraiza-Irigoyen C; Del Castillo-Codes I; Olza J; Plaza-Díaz J; Fontana L; Migueles JH; Olivares M; Gil Á; Gomez-Llorente C
    BMC Complement Altern Med; 2018 Nov; 18(1):306. PubMed ID: 30453950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice.
    Balakumar M; Prabhu D; Sathishkumar C; Prabu P; Rokana N; Kumar R; Raghavan S; Soundarajan A; Grover S; Batish VK; Mohan V; Balasubramanyam M
    Eur J Nutr; 2018 Feb; 57(1):279-295. PubMed ID: 27757592
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Liu Y; Hoang TK; Taylor CM; Park ES; Freeborn J; Luo M; Roos S; Rhoads JM
    Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G969-G981. PubMed ID: 33787352
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Abot A; Pomié N; Astre G; Jaomanjaka F; Marchand P; Cani PD; Roudier N; Knauf C
    Int J Food Sci Nutr; 2024 Feb; 75(1):58-69. PubMed ID: 37921224
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Wang G; Yang S; Sun S; Si Q; Wang L; Zhang Q; Wu G; Zhao J; Zhang H; Chen W
    Front Cell Infect Microbiol; 2020; 10():423. PubMed ID: 32974216
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Feng X; Ding L; Ma G; Zhang Y; Sun Y; Li Z; Tao X; Ali A; Wang D; Wu L
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice.
    Wang J; Tang H; Zhang C; Zhao Y; Derrien M; Rocher E; van-Hylckama Vlieg JE; Strissel K; Zhao L; Obin M; Shen J
    ISME J; 2015 Jan; 9(1):1-15. PubMed ID: 24936764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactic acid bacteria reduce diabetes symptoms in mice by alleviating gut microbiota dysbiosis and inflammation in different manners.
    Wang G; Si Q; Yang S; Jiao T; Zhu H; Tian P; Wang L; Li X; Gong L; Zhao J; Zhang H; Chen W
    Food Funct; 2020 Jul; 11(7):5898-5914. PubMed ID: 32572400
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Yang B; Zheng F; Stanton C; Ross RP; Zhao J; Zhang H; Chen W
    Foods; 2021 Sep; 10(9):. PubMed ID: 34574191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome.
    Natividad JM; Agus A; Planchais J; Lamas B; Jarry AC; Martin R; Michel ML; Chong-Nguyen C; Roussel R; Straube M; Jegou S; McQuitty C; Le Gall M; da Costa G; Lecornet E; Michaudel C; Modoux M; Glodt J; Bridonneau C; Sovran B; Dupraz L; Bado A; Richard ML; Langella P; Hansel B; Launay JM; Xavier RJ; Duboc H; Sokol H
    Cell Metab; 2018 Nov; 28(5):737-749.e4. PubMed ID: 30057068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactobacillus rhamnosus Strain LRH05 Intervention Ameliorated Body Weight Gain and Adipose Inflammation via Modulating the Gut Microbiota in High-Fat Diet-Induced Obese Mice.
    Chen YT; Chiou SY; Hsu AH; Lin YC; Lin JS
    Mol Nutr Food Res; 2022 Jan; 66(1):e2100348. PubMed ID: 34796638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The probiotic Lactobacillus fermentum 296 attenuates cardiometabolic disorders in high fat diet-treated rats.
    Cavalcante RGS; de Albuquerque TMR; de Luna Freire MO; Ferreira GAH; Carneiro Dos Santos LA; Magnani M; Cruz JC; Braga VA; de Souza EL; de Brito Alves JL
    Nutr Metab Cardiovasc Dis; 2019 Dec; 29(12):1408-1417. PubMed ID: 31640890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.